A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

October 31, 2018

Conditions
Neuroblastoma
Interventions
BIOLOGICAL

Activated T lymphocyte

intravenous dripping of 200 ml (10\^9\~2\*10\^10 lymphocytes) for 1 hour.

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT01802138 - A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma | Biotech Hunter | Biotech Hunter